Growth and stature—postnatal reduced linear growth seems to be a salient and consistent feature of SLC39A13 deficiency; this is in contrast to other types of connective tissue disease and EDS types, where short stature is not a prominent feature. This evidence concerns the gene SLC39A13 and connective tissue disorder.